Prime Medicine, Inc. logo PRME - Prime Medicine, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 5
HOLD 4
SELL 0
STRONG
SELL
0
| PRICE TARGET: $17.25 DETAILS
HIGH: $23.00
LOW: $12.00
MEDIAN: $17.00
CONSENSUS: $17.25
UPSIDE: 480.81%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2019 Q4
Revenue
Revenue 0.9 0.8 1.2 1.1 1.5 2.2 0.2 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 1.9 0 44.0 1.9 0 0 0 0 1.3 0 0 0 0 0 0 0 0 0 0 1.2 4.6 1.3 0
Gross Profit (1) 0.8 (42.8) (0.7) 1.5 2.2 0.2 0 (0.7) 0 0 0 0 0 0 0 0 0 0 (1.2) (4.6) (1.3) 0
Operating Expenses
R&D Expenses 34.1 34.7 44.0 41.4 40.6 34.1 40.3 43.1 37.8 41.5 41.0 34.6 30.9 29.1 25.0 18.9 13.7 52.9 7.4 5.7 4.6 1.3 0.9
SG&A Expenses 17.4 14.7 11.2 13.1 13.3 12.3 14.1 12.6 11.2 13.1 10.5 10.7 9.2 9.6 6.6 7.4 6.2 7.2 3.0 1.2 1.4 1.3 1.3
Other Expenses (1.9) 0 (44.0) (1.9) 0 0 0 0 (1.3) 13.5 (0.0) 0 0 0 0 0 0 0 0 0 (4.6) (1.3) 0
Operating Expenses 49.7 49.4 11.2 52.6 53.8 46.4 54.4 55.7 47.6 68.0 51.5 45.3 40.0 38.7 31.7 26.3 19.9 60.1 10.4 6.9 1.4 1.3 2.2
Operating Income
Operating Income (50.7) (48.6) (54.0) (53.4) (52.4) (44.2) (54.2) (55.7) (48.3) (68.0) (51.5) (45.3) (40.0) (38.7) (31.7) (26.3) (19.9) (60.1) (10.4) (8.0) (6.0) (2.6) (2.2)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 1.5 1.1 1.1 1.3 1.2 1.5 0.7 0.6 0.7 0 0.4 0.6 0 0 0 0 0 0 0 0 0 0 0
Profitability
EBITDA (48.8) (46.7) (48.7) (51.5) (50.7) (42.5) (52.7) (54.1) (47.0) (53.3) (50.2) (44.1) (39.0) (37.8) (31.0) (25.9) (19.6) (59.8) (10.3) 2.9 (5.9) (2.6) (2.2)
EBIT (50.7) (48.6) (50.6) (53.4) (52.4) (44.2) (54.2) (55.7) (48.3) (54.5) (51.5) (45.3) (40.0) (38.7) (31.7) (26.3) (19.9) (60.1) (10.4) 1.7 (6.0) (2.6) (2.2)
Income Before Tax (49.1) (46.1) (50.6) (52.6) (51.9) (42.3) (52.5) (55.5) (45.6) (65.6) (50.8) (42.4) (39.6) (39.5) (29.1) (29.8) (24.4) (61.5) (18.8) 1.7 (87.3) (0.7) (2.5)
Income Tax Expense 0 0 0 0 0 0 0 (0.1) 0.1 0 (0.1) 0.0 (0.2) (0.2) 0.2 (0.4) (0.5) 1.4 (2.4) 1.1 (0.6) 1.9 0.0
Net Income (49.1) (46.1) (50.6) (52.6) (51.9) (42.3) (52.5) (55.3) (45.8) (65.6) (50.7) (42.4) (39.4) (39.3) (35.7) (29.3) (23.8) (62.9) (16.4) 0.6 (86.7) (2.6) (2.5)
Per Share Data
EPS (Basic) -0.28 -0.26 -0.32 -0.41 -0.40 -0.36 -0.44 -0.46 -0.44 -0.67 -0.55 -0.47 -0.44 -0.42 -0.37 -0.37 -0.31 -0.72 -0.24 -0.04 -0.92 -0.04 -0.03
EPS (Diluted) -0.28 -0.26 -0.32 -0.41 -0.40 -0.36 -0.44 -0.46 -0.44 -0.67 -0.55 -0.47 -0.44 -0.42 -0.37 -0.37 -0.31 -0.72 -0.24 -0.04 -0.92 -0.04 -0.03
Shares Outstanding 177.1 148.8 160.5 129.2 130.9 118.6 119.8 119.2 104.5 97.4 91.8 90.5 89.1 97.2 97.2 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.7
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
Current Assets
Cash & Cash Equivalents 64.1 63.0 71.4 53.8 91.9 182.5 118.0 55.6 94.2 41.6 44.0 120.6 133.5 187.6 47.9 92.2 164.2 185.4 200.7
Short-Term Investments 71.4 114.6 137.0 47.9 52.4 8.0 57.5 107.3 116.6 80.1 121.4 87.0 116.1 106.3 98.7 88.4 47.0 84.2 99.3
Net Receivables 0 0 0 0.1 0.0 0 55 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 2.4 3.6 23.0 19.4 16.5 14.7 9.5 3.7 2.7 2.3 19.2 10.9 4.0 0.2 0 0 0 0 0
Total Current Assets 137.9 181.3 231.4 121.3 163.8 211.9 246.1 170.8 217.7 143.0 184.5 218.5 253.5 296.6 148.8 181.6 212.0 270.6 300.4
Non-Current Assets
Property, Plant & Equipment 142.2 146.7 139.9 144.0 150.3 71.6 72.7 75.4 79.5 36.6 39.3 47.1 48.3 48.6 47.3 47.6 15.7 15.7 14.0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 13.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 14.7 14.7 13.7 0 14.1 14.1 14.1 13.5 14.3 14.3 15.3 15.3 15.1 15.1 19.1 18.4 16.9 15.6 0.8
Total Non-Current Assets 156.8 161.4 153.6 157.7 164.4 85.6 86.7 88.9 93.7 50.9 54.6 62.4 63.4 63.7 66.4 66.0 32.6 31.3 14.8
Total Assets 294.7 342.7 385.0 279.0 328.2 297.5 332.8 259.7 311.4 193.9 239.1 280.9 316.9 360.3 215.3 247.6 244.6 301.9 315.2
Current Liabilities
Account Payables 12.3 8.9 9.4 6.4 10.0 11.4 5.4 4.6 10.1 19.5 14.1 5.5 4.6 4.3 4.1 5.9 3.2 1.4 1.4
Short-Term Debt 8.5 8.1 7.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 7.3 7.8 7.0 8.3 8.2 7.1 9.3 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 8.1 12.6 11 6.9 6.9 10.2 18.7 6.0 4.0 9.9 6.5 5.3 2.3 7.0 4.3 2.8 1.1 14.7 0.0
Total Current Liabilities 36.3 37.4 35.0 34.1 34.3 38.0 37.9 20.7 24.4 56.4 39.4 28.7 23.9 26.7 22.2 23.8 12.9 58.0 9.5
Non-Current Liabilities
Long-Term Debt 106.0 108.3 110.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0.1 0 0 0.1 0.1 0.3 0.5 0.3 0 1.2 0
Other Non-Current Liabilities 75.8 76.1 77.8 71.6 0 6 0 0 0 0 0 0 0 0 0 0 0.7 0 0
Total Non-Current Liabilities 181.7 184.4 188.2 184.0 187.0 106.4 105.4 42.4 43.2 4.4 5.8 12.0 14.3 17.3 20.3 23.0 2.8 4.3 4.3
Total Liabilities 218.0 221.9 223.2 218.1 221.2 144.4 143.3 63.1 67.6 60.8 45.2 40.8 38.1 44.0 42.6 46.9 15.7 62.3 13.8
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0.0 0 0.0
Retained Earnings (937.5) (888.4) (842.3) (791.7) (739.1) (687.2) (644.9) (592.4) (537.1) (491.3) (425.7) (375.0) (332.6) (293.2) (253.9) (224.6) (195.2) (171.4) (108.5)
Accumulated Other Comprehensive Income (0.0) 0.1 0.0 (0.0) (0.0) 0.0 0.0 (0.1) (0.1) (0.0) (0.1) (0.3) (0.2) (0.4) (0.5) (0.1) (0.0) (0.0) (0.0)
Total Stockholders' Equity 76.7 120.9 161.8 60.9 106.9 153.1 189.5 196.6 243.8 133.1 194.0 240.1 278.8 316.3 172.7 200.7 228.9 239.6 301.4
Total Liabilities & Equity 294.7 342.7 385.0 279.0 328.2 297.5 332.8 259.7 311.4 193.9 239.1 280.9 316.9 360.3 215.3 247.6 244.6 301.9 315.2
Debt Metrics
Total Debt 114.5 116.4 118.1 119.7 121.2 40.8 41.2 41.6 43.8 13.6 17.0 25.4 26.0 28.7 31.4 34.7 8.1 10.4 9.7
Net Debt 50.4 53.4 46.7 65.9 29.3 (141.7) (76.7) (14.0) (50.4) (27.9) (26.9) (95.1) (107.5) (158.9) (16.5) (57.5) (156.2) (175.0) (190.9)
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2019 Q4
Operating Activities
Net Income (49.1) (46.1) (50.6) (52.6) (51.9) (42.3) (52.5) (55.3) (45.8) (65.6) (50.7) (42.4) (39.4) (39.3) (29.4) (29.3) (23.8) (62.9) (16.4) 0.6 (86.7) (2.6) (2.5)
Depreciation & Amortization 1.9 0.5 1.9 1.5 1.5 1.7 1.6 1.5 1.3 1.2 1.2 4.6 3.9 0.9 0.6 0.4 0.3 0.2 0.2 0.1 0.1 0.0 0
Stock-Based Compensation 0 4.5 12.7 6.3 5.7 5.9 6.8 0 5.2 4.4 4.2 0 0 2.6 1.4 1.3 1.1 1.1 0.3 0.1 0.2 (0.3) 0.2
Change in Working Capital (2.5) 1.2 0.6 0.5 (7.7) 48.9 3.6 (4.7) (30.1) 14.4 2.4 (5.6) (8.6) 1.2 (3.8) 1.6 (34.3) 31.6 (0.8) (0.7) 0.1 0.5 0.5
Other Non-Cash Items 7.1 2.6 0.3 2.9 3.5 2.0 14.6 13.2 1.5 6.3 3.8 2.5 2.8 4.2 0.8 6.2 6.5 15.6 9.4 (6.5) 81.4 (0.2) 0.5
Operating Cash Flow (42.7) (37.3) (35.0) (41.4) (48.9) 16.2 (25.9) (45.5) (67.7) (43.9) (39.2) (40.8) (41.6) (30.7) (30.1) (20.2) (50.8) (13.2) (9.6) (6.4) (4.9) (2.5) (1.3)
Investing Activities
Capital Expenditure (0.2) (0.3) (0.2) (1.6) (2.4) (1.8) (1.3) (1.9) (2.3) (1.8) (2.9) (2.0) (2.0) (4.8) (4.8) (4.8) (1.7) (0.4) (1.8) (0.9) (1.0) (0.3) 0
Acquisitions 0 0 0 0 0 0 0 0 0 (0.0) 0.0 0 0 0 0.0 0 0 0 0 0 0 0 0
Purchases of Investments (7.3) (15.9) (134.3) (6.9) (48.3) 16.9 (10.4) (28.7) (107.2) (4.4) (54.9) 0.0 (45.7) (33.9) (14.7) (74.7) 0 (0.1) (5.9) 0 0 0 0
Sales/Maturities of Investments 50.9 44.5 42.4 11.2 3 32.9 61.3 37.5 72.5 47.5 20.0 30 35 25 6 29.5 32.5 13 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0.3 0.7 0 0 0.0 (0.0) (0.2) 0 (0.0) (0.0) (0.7) 0.1 (0.3) 0.1 (76.2) 0.0 (0.1) 0
Investing Cash Flow 43.4 28.3 (92.1) 2.8 (47.7) 48.3 50.3 6.9 (37.0) 41.3 (37.8) 27.9 (12.7) (13.7) (13.5) (50.8) 30.9 12.2 (7.6) (77.2) (1.0) (0.4) 0
Financing Activities
Net Debt Issuance 0 (6) 0 0 6 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 145.5 6 0 0 0 0.4 (151.3) 19.3 0 0 0 0 (1.2) (0.7) (0.6) (1.3) (1.1) 0 268.1 2.3 35.0 0
Financing Cash Flow 0.4 0.6 144.8 0.2 6 0.0 38.5 0.0 157.3 0.2 0.3 0.1 0.1 184.1 (0.7) (0.6) (1.3) (1.1) (0.0) 268.1 2.3 35.0 10.0
Cash Position
Net Change in Cash 1.1 (8.4) 17.6 (38.4) (90.6) 64.5 62.9 (38.6) 52.6 (2.4) (76.6) (12.9) (54.2) 139.7 (44.3) (71.6) (21.2) (2.1) (17.2) 184.5 (3.5) 37.0 8.6
Cash at Beginning 63.0 71.4 53.8 105.9 196.5 118.0 69.1 94.2 41.6 44.0 134.1 133.5 187.6 61.4 105.7 177.4 198.5 200.7 217.9 33.4 37.0 0 0
Cash at End 64.1 63.0 71.4 67.5 105.9 182.5 132.0 55.6 94.2 41.6 57.5 120.6 133.5 201.1 61.4 105.7 177.4 198.5 200.7 217.9 33.4 37.0 8.6
Free Cash Flow (42.9) (37.5) (35.3) (43.0) (51.3) 14.5 (27.2) (47.4) (70.0) (45.7) (42.1) (42.8) (43.6) (35.5) (34.9) (25.0) (52.5) (13.6) (11.4) (7.3) (5.9) (2.8) (1.3)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2019 Q4
Income Statement
Revenue 0.9 0.8 1.2 1.1 1.5 2.2 0.2 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit (1) 0.8 (42.8) (0.7) 1.5 2.2 0.2 0 (0.7) 0 0 0 0 0 0 0 0 0 0 (1.2) (4.6) (1.3) 0
Operating Income (50.7) (48.6) (54.0) (53.4) (52.4) (44.2) (54.2) (55.7) (48.3) (68.0) (51.5) (45.3) (40.0) (38.7) (31.7) (26.3) (19.9) (60.1) (10.4) (8.0) (6.0) (2.6) (2.2)
Net Income (49.1) (46.1) (50.6) (52.6) (51.9) (42.3) (52.5) (55.3) (45.8) (65.6) (50.7) (42.4) (39.4) (39.3) (35.7) (29.3) (23.8) (62.9) (16.4) 0.6 (86.7) (2.6) (2.5)
EPS (Diluted) -0.28 -0.26 -0.32 -0.41 -0.40 -0.36 -0.44 -0.46 -0.44 -0.67 -0.55 -0.47 -0.44 -0.42 -0.37 -0.37 -0.31 -0.72 -0.24 -0.04 -0.92 -0.04 -0.03
Balance Sheet
Cash & Equivalents 64.1 63.0 71.4 53.8 91.9 182.5 118.0 55.6 94.2 41.6 44.0 120.6 133.5 187.6 47.9 92.2 164.2 185.4 200.7
Total Assets 294.7 342.7 385.0 279.0 328.2 297.5 332.8 259.7 311.4 193.9 239.1 280.9 316.9 360.3 215.3 247.6 244.6 301.9 315.2
Total Debt 114.5 116.4 118.1 119.7 121.2 40.8 41.2 41.6 43.8 13.6 17.0 25.4 26.0 28.7 31.4 34.7 8.1 10.4 9.7
Stockholders' Equity 76.7 120.9 161.8 60.9 106.9 153.1 189.5 196.6 243.8 133.1 194.0 240.1 278.8 316.3 172.7 200.7 228.9 239.6 301.4
Cash Flow
Operating Cash Flow (42.7) (37.3) (35.0) (41.4) (48.9) 16.2 (25.9) (45.5) (67.7) (43.9) (39.2) (40.8) (41.6) (30.7) (30.1) (20.2) (50.8) (13.2) (9.6) (6.4) (4.9) (2.5) (1.3)
Capital Expenditure (0.2) (0.3) (0.2) (1.6) (2.4) (1.8) (1.3) (1.9) (2.3) (1.8) (2.9) (2.0) (2.0) (4.8) (4.8) (4.8) (1.7) (0.4) (1.8) (0.9) (1.0) (0.3) 0
Free Cash Flow (42.9) (37.5) (35.3) (43.0) (51.3) 14.5 (27.2) (47.4) (70.0) (45.7) (42.1) (42.8) (43.6) (35.5) (34.9) (25.0) (52.5) (13.6) (11.4) (7.3) (5.9) (2.8) (1.3)